Evidence map›Paper›PMID 35448640›Full record

ArticleJournal of fungi (Basel, Switzerland)2022

Biocontrol Activity of

Jinxz Pollard-Flamand, Julie Boulé, Miranda Hart, José Ramón Úrbez-Torres

Open access · goldAbstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Journal of fungi (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Frontiers in plant science · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Frontiers in microbiology · 2023
    Review
  14. Article
  15. The Biocontrol Potential of EndophyticPathogens (Basel, Switzerland) · 2022
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jinxz Pollard-FlamandSummerland Research and Development Centre, Agriculture and Agri-Food Canada, 4200 Highway 97, Summerland, BC V0H 1Z0, Canada.
Julie BouléSummerland Research and Development Centre, Agriculture and Agri-Food Canada, 4200 Highway 97, Summerland, BC V0H 1Z0, Canada.
Miranda HartDepartment of Biology, The University of British Columbia Okanagan, 3187 University Way, Kelowna, BC V1V 1V7, Canada.ORCID 0000-0002-2503-8326
José Ramón Úrbez-TorresSummerland Research and Development Centre, Agriculture and Agri-Food Canada, 4200 Highway 97, Summerland, BC V0H 1Z0, Canada.
Agriculture and Agri-Food Canada · CAUniversity of British Columbia · CA

Funding

Agriculture and Agriculture-Food Canada n/aBritish Columbia Wine Grape Council n/aCanadian Grapevine Certification Network n/a
6 · The paper itself

Abstract

Botryosphaeria dieback (BD) is a grapevine trunk disease (GTD) causing significant yield losses and limiting the lifespan of vineyards worldwide. Fungi responsible for BD infect grapevines primarily through pruning wounds, and thus pruning wound protection, using either synthetic chemicals or biological control agents (BCAs), is the main available management strategy. However, no products to control GTDs are currently registered in Canada. With a focus on more sustainable grapevine production, there is an increasing demand for alternatives to chemical products to manage GTDs. Accordingly, the objective of this study was to identify

Indexed as

biocontrolbotryosphaeria diebackDiplodia seriatagrapevine trunk diseasesNeofusicoccum parvumtranslation elongation factor one alphaTrichodermaVitis vinifera

Identifiers

PMID35448640
PMCPMC9030288
OpenAlexW4223910646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.